Scientific Session Abstracts
International Cancer Study & Therapy Conference
April 04-06, 2016, Baltimore, USA
Giant obscurins: Novel tumor and metastasis suppressors in breast cancer
Madridge J Cancer Stud Res. 2016
Targeting RET signaling pathway: A novel molecular mechanism of action of metformin in pancreatic cancer prevention and treatment
Madridge J Cancer Stud Res. 2016
Zestern Analysis, from theory into practice in high throughput immunoblot analysis
Madridge J Cancer Stud Res. 2016
The suppressive effect of organism senescence on cancers
Madridge J Cancer Stud Res. 2016
Prevalence and predictors of non-adherent to breast cancer screening: Perspective and preferences of hospitalized women
Madridge J Cancer Stud Res. 2016
Targeting the YAP1/COX2/SOX2 signaling axis eliminates cancer stem cells in urothelial carcinoma
Madridge J Cancer Stud Res. 2016
Non-translation initiation functions of eIF3g in breast cancer
Madridge J Cancer Stud Res. 2016
Novel benzothiazole-piperazine derivatives with anticancer activity
Madridge J Cancer Stud Res. 2016
Superiority of anti-cancer drugs specific to acidic cancer nests
Madridge J Cancer Stud Res. 2016
Inhibitors of DNA glycosylases as potential therapeutic drugs in cancer
Madridge J Cancer Stud Res. 2016
Metarrestin blocks metastasis by impairing a new function of EEF1A involved in modulation of ribosomal biogenesis
Madridge J Cancer Stud Res. 2016
ARF proteins are key molecular switch controlling breast cancer invasiveness
Madridge J Cancer Stud Res. 2016
Synergistic and coordinated actions of three DNMT enzymes for the establishment and maintenance of DNA methylation patterns
Madridge J Cancer Stud Res. 2016
Taspine derivatives inhibited tumor angiogenesis by targeting EphrinB2 and regulating its signaling players
Madridge J Cancer Stud Res. 2016
Psychological risk factors in cancer diseases
Madridge J Cancer Stud Res. 2016
Mechanistic study of human DNA replication proteins that regulate cell proliferation and differentiation
Madridge J Cancer Stud Res. 2016
Circulating DNA as a source of novel types of cancer biomarkers
Madridge J Cancer Stud Res. 2016
Clinical significance of MicroRNA21 expression in colon cancer
Madridge J Cancer Stud Res. 2016
Lung cancer molecular profiling in clinical practice
Madridge J Cancer Stud Res. 2016
Detection of circulating colorectal cancer cells using MAGE A1-6 and hTERT RT-PCR
Madridge J Cancer Stud Res. 2016
Artificial light at night as a source of environmental pollution - Melatonin suppression and breast cancer
Madridge J Cancer Stud Res. 2016
Design of new18F-labelled radiopharmaceuticals for brain tumor imaging
Madridge J Cancer Stud Res. 2016
Using metabolism to differentiate aggressive versus indolent prostate cancer for diagnosis and treatment
Madridge J Cancer Stud Res. 2016
Review of the relationships between lifestyle behaviors, telomere length, stem cells, and cancer
Madridge J Cancer Stud Res. 2016
Plasma thioredoxin reductase (TrxR) is a novel clinical biomarker of the early-stage diagnosis and treatment of cancer
Madridge J Cancer Stud Res. 2016
Real-time tracking and bio-imaging of cancer cells based on novel nanoscaled probes
Madridge J Cancer Stud Res. 2016
Gut microbiome: A potential regulator of cancer stem cells and colon carcinogenesis
Madridge J Cancer Stud Res. 2016
Understanding how distinct tumor cell clones communicate in glioblastoma
Madridge J Cancer Stud Res. 2016
A randomized phase 2 trial of ascorbic acid in combination with Docetaxel in men with metastatic prostate cancer
Madridge J Cancer Stud Res. 2016
In vitro treatment of mesothelioma with cell cycle inhibition and pemetrexed
Madridge J Cancer Stud Res. 2016
Metformin may reduce oral cancer risk in patients with type 2 diabetes
Madridge J Cancer Stud Res. 2016
Crocin (saffron’s biomolecule) is a potent preventive agent against liver cancer
Madridge J Cancer Stud Res. 2016
Dissecting molecular networks of leptin in breast cancer: Complexities and opportunities
Madridge J Cancer Stud Res. 2016
Using cystine knot proteins to retarget oncolytic measles virus for tumor-associated integrins
Madridge J Cancer Stud Res. 2016
A new method of the initial dose of 120mg regorafenib for metastatic colorectal cancer as a salvage-line monotherapy
Madridge J Cancer Stud Res. 2016
The ratio between distinct subsets dictates overall neutrophil contribution in cancer
Madridge J Cancer Stud Res. 2016
Tumorigenesis of NIH3T3 cells induced by the exogenously over-expression of the novel tumor antigen OVA66
Madridge J Cancer Stud Res. 2016
MS17-38 mAb targeting of PODXL-v2 inhibits gastric cancer growth and metastasis
Madridge J Cancer Stud Res. 2016
ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion
Madridge J Cancer Stud Res. 2016